drugset
drugset / Trial / NCT02047578

Targeted Busulfan, Fludarabine, Etoposide Conditioning Regimen for HSCT in Childhood and Adolescent ALL.

NCT02047578 ↗

Phase 2 Unknown 38 enrolled Seoul National University Hospital
NaSingle-groupOpen-labelTreatment

Summary

To evaluate the outcome of hematopoietic stem cell transplantation using targeted busulfan, fludarabine, etoposide conditioning regimen in childhood and adolescent ALL.

Timeline

Start
2014-02-05
Primary completion
2023-12
Completion
2023-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Busulfan Small molecule 80 mg/m2 Intravenous
Subject Busulfan Small molecule 120 mg/m2 Intravenous

Indications

acute lymphoblastic leukemia